Could a Type 2 Diabetes Drug Tackle Kidney Stones?
A pooled data analysis of trials of the SGLT2 inhibitor empagliflozin in type 2 diabetes suggests it may lower the risk of kidney stones. However, this is early research.
Source: medscape.com
Adults Without News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Adults Without. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Adults Without Today - Breaking & Trending Today